NeuroVision Diagnostics

About

NeuroVision Diagnostics provides telehealth services focused on cognitive neurology. Their offerings include a proprietary retinal imaging platform that utilizes cloud-based AI software to identify amyloid signatures in the retina, which are indicators of Alzheimer's disease and Cerebral Amyloid Angiopathy (CAA). They also conduct studies to validate their technology for predicting CAA and ARIA, which is a side effect associated with Alzheimer's treatments. The company addresses gaps in the diagnostic and care pathway for cognitive neurology through screening and triaging patients, as well as providing lifestyle change coaching and genetic testing.